Lexeo Therapeutics (LXEO) Preferred Shares (2022)

Lexeo Therapeutics has reported Preferred Shares for 1 years, with the latest figure at $185.6 million in Q4 2022.

• Quarterly Preferred Shares changed N/A year-over-year to $185.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $185.6 million (changed N/A YoY) and the FY2022 annual result came in at $185.6 million, changed N/A from the prior year.
• Preferred Shares steadied at $185.6 million in Q4 2022 per LXEO's latest filing.
• Over five years, Preferred Shares peaked at $185.6 million in Q4 2022 and troughed at $185.6 million in Q4 2022.